NCT00517764View on ClinicalTrials.gov

Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression

NACompletedINTERVENTIONAL

Enrollment

299

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Depression

Interventions

DRUG

escitalopram

Patients started on 20mg of escitalopram and this dose was increased based on tolerability and therapeutic response to a maximum dose of 40mg by week 12. The trial was 16 weeks. The treatment trial has completed and is no longer accepting patients.

Trial Locations (2)

K7L 3N6

Queens University, Kingston

M5T 1R8

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors

collaborator

Queen's University

OTHER

lead

Centre for Addiction and Mental Health

OTHER

NCT00517764 - Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression | Biotech Hunter | Biotech Hunter